global view constructed of white lines

Blog

Acoustic Neuroma Treatment at Pacific Neuroscience Institute
March 12, 2024

Being an Empowered Acoustic Neuroma Patient

by Courtney Voelker

Receiving a diagnosis of acoustic neuroma (AN) can be overwhelming and frightening. However, taking an active role in your healthcare journey is crucial to ensuring the best possible outcome.

Living a Brighter Future - Janna's Grateful Patient Story Blog Feature Image
February 15, 2024

From a Rare Brain Tumor Diagnosis to Law School: A Young Woman’s Courageous Battle

by Brianna Rauchman

Janna was 21 when her college journey took an unexpected detour. After experiencing hearing loss, An MRI scan revealed a rare brain tumor.

Pacific Neuroscience Institute's Physicians Receive Distinguished 2024 Healthcare Awards blog feature image
January 25, 2024

Pacific Neuroscience Institute’s Physicians Receive Distinguished 2024 Healthcare Awards

by Brianna Rauchman

Pacific Neuroscience Institute® (PNI®) celebrates significant healthcare milestones in 2024! Numerous esteemed PNI physicians were honored with Castle Connolly Top Doctor and Super Doctors awards, showcasing their dedication to clinical excellence and professional achievement.

Promising Progress Rare Spine Cancer Shows Positive Response in Clinical Trial at Providence Saint John’s Health Center’s Cancer Institute blog feature image
December 4, 2023

Promising Progress: Rare Spine Cancer Shows Positive Response in Clinical Trial at Providence Saint John’s Health Center’s Cancer Institute

by Guest Author

SANTA MONICA (Dec. 4, 2023) — Promising results of a pilot study at Providence Saint John’s Health Center to treat a rare form of cancer of the spine and skull base were published today by the journal Clinical Cancer Research.

Dr. Akanksha Sharma standing in the institute's hallway
October 23, 2023

Dr. Akanksha Sharma’s Heartfelt Message for the Brain Tumor Community & Beyond

by Akanksha Sharma

During the ABTA Brain Tumor 5K Walk & Run event, Akanksha Sharma, MD, neuro-oncologist, neurologist, and palliative care specialist at Pacific Neuroscience Institute® (PNI ®), delivered a heartfelt message. In her speech, she shed light on the profound impact of brain tumors, the challenges that patients face, and shared inspiring advancements in research.

October 19, 2023

Charting the Brain, in Great Detail | Dr. Garni Barkhoudarian & Josh Emerson

by Anthony Effinger

When not practicing world-class neurosurgery, Dr. Garni Barkhoudarian instructs aspiring surgeons at the Neuroanatomical Skills / Microdissection Anatomy Lab. His work there advances minimally invasive surgical techniques and provides training opportunities for neurosurgeons. Josh Emerson, an artist turned medical illustrator, creates intricate anatomical illustrations at PNI, where he collaborates with Dr. Barkhoudarian. Together, they meticulously map the human body's most crucial structures, combining traditional and digital techniques.

CNS 2023 banner RT
September 19, 2023

Pacific Neuroscience Institute Leading Neuroscience Activities Across the Nation

by Garni Barkhoudarian

Faculty members from Pacific Neuroscience Institute® Medical Group and PNI Foundation had a strong showing at the Congress of Neurological Surgeons (CNS) Annual meeting in Washington D.C.  September 9-13, 2023.

Brain tumor graphic
July 20, 2023

Innovations in Brain Tumor Surgery

by Zara Jethani

Daniel F. Kelly, MD, Co-Founder of Pacific Neuroscience Institute, discusses innovations in endoscopic surgery at PNI.

July 19, 2023

Glioblastoma Awareness Day: Confronting the Challenges of a Devastating Brain Tumor

by Brianna Rauchman

Today, July 19, 2023, marks the observance of Glioblastoma Awareness Day. Glioblastoma (GBM) is an infamous form of brain cancer, presenting immense difficulties in its treatment.

rGBM Phase 2 Clinical Trial Results
June 29, 2023

Trial Results Offer Hope for Improved rGBM Survival Outcomes

by Guest Author

Expert neuro-oncologist Santosh Kesari, MD, PhD, Director of Neuro-oncology at Pacific Neuroscience Institute and Chair and Professor of the Department of Translational Neurosciences at Saint John’s Cancer Institute, published the results from a phase 2 clinical trial for recurrent glioblastoma (rGBM), offering hope for improved survival outcomes and pushing novel treatment one step closer to FDA approval.

Last updated: June 30th, 2023